Close Menu

NEW YORK (360Dx) – During December, a month in which legislators from the House and Senate released a new version of a draft bill incorporating the US Food and Drug Administration's ideas for diagnostics regulation, BioMérieux, DiaSorin, and GenMark Diagnostics were among the companies that received clearances for their in vitro diagnostic tests, according to the FDA website.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.